NN7088-4029 A multinational, prospective, open labelled, non-controlled, non-interventional post-authorisation study of turoctocog alfa pegol (N8-GP) during long-term routine prophylaxis and treatment of bleeding episodes in patients with haemophilia A (pathfinder 9)

Documents

Study protocol

Initial protocol

4029-protocol-eu-pas-reg-redacted

Updated protocol

_ Protocol 4029 protocol eu-pas-reg redacted (1)

First published: 22/02/2024

Study results

Study report

Study report

4029 progress report eu-pas-reg 01 redacted

4029 progress report eu-pas-reg 02 redacted

Other information

Study, other information

4029 progress report eu-pas-reg 02 redacted.pdf